Coronary Restenosis: all 98 studies
Page 1 of 1. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.
- The PICCOLETO XIII REVEAL-DCB Cohort A StudyNot yet recruitingNCT07868523
- Disease Characteristics of R-CADNot yet recruitingNCT07239921
- Restrospective Analysis of MACE in Patients Treated With Drug-elluting Balloons.RecruitingNCT06972225
- Clinical Features, Current Treatment and Clinical Outcomes in Patients With INR-CAD: a Cohort StudyRecruitingNCT06845410
- COMPLEX Registry - a Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting with CompLEX and Calcified Coronary Artery DiseaseRecruitingNCT06075602
- Disease Characteristics of IR-CAD: a Case-control StudyRecruitingNCT06007248
- Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort StudyRecruitingNCT05860400
- Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5RecruitingNCT05544864Not applicable
- SIROOP Registry - a Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated with SIROlimus or Paclitaxel Eluting Balloon CathetersRecruitingNCT04988685
- Abbott Vascular Medical Device RegistryRecruitingNCT04573660
- SELUTION SLR™ 014 In-stent RestenosisActive, not recruitingNCT04280029Not applicableResults posted
- SOLEMN Study - Synergy Optical Coherence Tomography in Left Main PCITerminatedNCT03474432Not applicableResults posted
- XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm StudyCompletedNCT01894152Results posted
- ABSORB FIRST is a Registry Designed to Evaluate the Safety and Performance of Absorb Bioresorbable Vascular Scaffold (Absorb BVS) Used in Real-world Patients.CompletedNCT01759290Results posted
- XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm StudyCompletedNCT01249027Results posted
- EXCEL Clinical TrialCompletedNCT01205776Not applicableResults posted
- XIENCE V: SPIRIT WOMEN Sub-studyCompletedNCT01182428Phase 4Results posted
- XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT)CompletedNCT01178268Phase 4Results posted
- SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study)CompletedNCT01171820Phase 4Results posted
- XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort)CompletedNCT01120379Results posted
- A Clinical Evaluation of the XIENCE PRIME Small Vessel Everolimus Eluting Coronary Stent System in Japanese PopulationCompletedNCT01115933Not applicableResults posted
- XIENCE V® USA Dual Antiplatelet Therapy (DAPT) CohortCompletedNCT01106534Phase 4Results posted
- XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for JapanCompletedNCT01086228Results posted
- ABSORB EXTEND Clinical InvestigationCompletedNCT01023789Not applicableResults posted
- Paclitaxel Releasing Balloon in Patients Presenting With In-Stent RestenosisCompletedNCT00961181Not applicableResults posted
- SPIRIT PRIME Clinical TrialCompletedNCT00916370Phase 3Results posted
- ABSORB Clinical Investigation, Cohort BCompletedNCT00856856Not applicableResults posted
- Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting StentsCompletedNCT00552669Phase 4Results posted
- EXecutive RCT: Evaluating XIENCE V® in a Multi Vessel DiseaseCompletedNCT00531011Phase 4Results posted
- SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)CompletedNCT00180479Phase 3Results posted
- Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent RestenosisCompletedNCT00124943Phase 1/2Results posted
- AnGiographic Performance With A Sirolimus-elutiNG Balloon in the TrEatment of De Novo CoronaRy Artery DiseaseCompletedNCT05471245Not applicable
- Resveratrol Excipient Paclitaxel Coated Balloon for Coronary TreatmentWithdrawnNCT05093244Not applicable
- STAR and Deferred Stenting StudyCompletedNCT05089864Not applicable
- PCI vs. CABG in UPLM-ISRCompletedNCT04968977
- Restenosis in Coronary Stents And Cutaneous HEaLingStatus unknownNCT04915391
- Physiology and Residual Ischemia After Percutaneous Coronary InterventionStatus unknownNCT04494750
- Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting StentsCompletedNCT04475380
- Concordance Between FFR and iFR for the Assessment of Intermediate Lesions in the Left Main Coronary Artery. A Prospective Validation of a Default Value for iFRActive, not recruitingNCT03767621
- Treatment of In-Stent Restenosis 2 StudyCompletedNCT03667313Phase 3
- BIOFLOW-SV All Comers RegistryTerminatedNCT03600948
- Metal Allergy In-Stent Restenosis StudyStatus unknownNCT03588962Not applicable
- Treatment of Coronary In-stent Restenosis (ISR) by a Sirolimus Coated or a Paclitaxel Coated BalloonCompletedNCT03242096Not applicable
- DEB Versus 2nd Generation DES in Patients With In-Scaffold Restenosis of Bioresorbable Vascular ScaffoldWithdrawnNCT03074305Not applicable
- REWARDS- In-stent RestenosisWithdrawnNCT03008772
- Compare the Efficacy and Safety of RESTORE DEB and SeQuent® Please in Chinese Patient With Coronary In-stent RestenosisCompletedNCT02944890Not applicable
- The Influence Cirrhosis of the Liver on the Coronary Re-stenosis (LTX- Stent Study)WithdrawnNCT02809248Not applicable
- Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX StentsStatus unknownNCT02508714Not applicable
- Absorb BVS vs. Drug Coated Balloon for Treatment Of ISRSuspendedNCT02474485Not applicable
- Trial of a Novel Paclitaxel-coated Balloon With Citrate Excipient for Restenosis in -Limus Analogue DESCompletedNCT02367495Not applicable
- Effect of Combination of Non-sLip Element Balloon (NSE) and druG-coated bAlloon (DCB) for In-steNT Restenosis LesionsStatus unknownNCT02300454Phase 4
- EGO-COMBO Clinical End-point Extension Study Beyond 36 MonthsCompletedNCT02263313
- DUrable Polymer-based STent CHallenge of Promus ElemEnt Versus ReSolute IntegrityStatus unknownNCT02175706Not applicable
- Comparison of Agent™ and SeQuent® Please Paclitaxel Coated Balloon Catheters in Coronary In-stent Restenosis (AGENT-ISR)CompletedNCT02151812Not applicable
- To Study the Safety and Clinical Outcomes of the Absorb Bioresorbable Vascular Scaffold (BVS) System in Patients With de Novo Lesions in Previously Untreated VesselsCompletedNCT01977534
- Drug-eluting Stents vs. Drug-coated Balloon for Preventing Recurrent In-stent RestenosisTerminatedNCT01967199Phase 4
- The ASSURE ROT Registry: Bioresorbable Vascular Scaffold Following Rotablation for Complex Coronary LesionsStatus unknownNCT01915420
- Intra-stent Tissue Evaluation Within BMS and DES > 3 Years Since ImplantationStatus unknownNCT01835301
- Comparison of BIOdegradable Polymer and DuRablE Polymer Drug-eluting Stents in an All COmeRs PopulaTion (BIO-RESORT)CompletedNCT01674803Not applicable
- Clinical Performance of the Pantera Lux Balloon Versus the Orsiro Stent in Patients With In-stent Restenosis.CompletedNCT01651390Not applicable
- A Randomized Clinical Evaluation of the BioFreedom™ StentStatus unknownNCT01623180Not applicable
- ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery DiseaseCompletedNCT01583608
- Safety and Efficacy Study of the DANUBIO Paclitaxel Eluting Balloon in In-Stent Restenosis Lesions (DEBREST)CompletedNCT01485068Not applicable
- Prognostic Assessment of Different Pattern of Bifurcation RestenosisWithdrawnNCT01411475
- DUrable Polymer-based STent CHallenge of Promus Element Versus ReSolute Integrity in an All Comers PopulationCompletedNCT01331707Phase 4
- EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel DiseaseCompletedNCT01310309
- In-stent Restenosis in Patients With Patent Previous Bare Metal StentCompletedNCT01296399
- OCT Evaluation of Healing of COMBO StentCompletedNCT01274234Phase 1/2
- The Effects of Bindarit in Preventing Stent RestenosisCompletedNCT01269242Phase 2
- Safety Study of a Bioresorbable Coronary StentCompletedNCT01262703Not applicable
- EXCEL Clinical Trial (Universal Registry)CompletedNCT01205789
- The Real-World Endeavor Resolute Versus XIENCE V Drug-Eluting Stent Study in TwenteCompletedNCT01066650Phase 4
- Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implanted in the Treatment of Restenosis in Non-coated Metallic Stent (BMS In-stent Restenosis) During a 2 Year Clinical Follow-up PeriodCompletedNCT00882219Phase 3
- Oral Sirolimus for In-Stent RestenosisCompletedNCT00859183Phase 4
- Per-cutaneous Intervention Based Paclitaxel and Sirolimus-Eluting Versus Bare Stents for the Treatment of de Novo Coronary Lesions (PAINT)CompletedNCT00752362Phase 4
- The SCRIPPS DES REAL WORLD RegistryCompletedNCT00714623
- SCRIPPS V: Intracoronary Brachytherapy for Recurrent Restenosis After Multiple Drug-Eluting StentsCompletedNCT00714545Phase 4
- XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-arm StudyCompletedNCT00631228
- Cost-Effectiveness Study in the Reduction of Coronary Restenosis With Sirolimus-Eluting StentsCompletedNCT00627900Phase 4
- Whole Genome Association Study to Identify and Validate Genes for Restenosis: CardioGene Validation ProposalCompletedNCT00589810
- Effects of Celecoxib On Restenosis After Coronary Intervention and Evolution of Atherosclerosis TrialStatus unknownNCT00500279Phase 4
- XIENCE V: SPIRIT WOMENCompletedNCT00496938Phase 4
- Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent ImplantationStatus unknownNCT00426049Phase 3
- Clinical and Angiographic Outcomes With Hyperglycemic Control Post PCICompletedNCT00412126Not applicable
- Treatment of in-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH - ISR II)CompletedNCT00409981Phase 1/2
- SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in EuropeCompletedNCT00402272Phase 4
- PIoglitazone for PrEvention of Restenosis in Diabetic PatientsStatus unknownNCT00376870Phase 3
- ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical InvestigationCompletedNCT00300131
- Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent RestenosisCompletedNCT00287573Phase 2/3
- Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary ArteriesCompletedNCT00248066Phase 2
- Serp-1 for the Treatment of Acute Coronary SyndromeTerminatedNCT00243308Phase 2
- PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic LesionsCompletedNCT00180466
- SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent SystemCompletedNCT00180310Phase 3
- Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by AngioplastyCompletedNCT00162357Phase 4
- Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary ArteriesCompletedNCT00148356Phase 2/3
- Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary ArteriesCompletedNCT00140101Phase 2
- Treatment of In-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH - ISR I)CompletedNCT00106587Phase 1/2
- A Blinded Study Conducted at Multiple Centers Evaluating Various Doses of an Investigational Agent (BO-653) Against Placebo, for Safety and Effectiveness in Preventing Post-Angioplasty Blood Vessel Re-Closure (Restenosis) in Stented Vessels.CompletedNCT00055510Phase 2/3